
Results
50
Mid-Large Cap Stocks
50 companies
Abbott India
Market Cap: ₹590.4b
Operates as a pharmaceutical company in India.
500488
₹27,784.15
7D
-0.8%
1Y
-17.5%
Procter & Gamble Health
Market Cap: ₹109.5b
Manufactures and markets pharmaceuticals and chemical products in India and internationally.
500126
₹6,597.45
7D
-1.9%
1Y
6.4%
Alembic Pharmaceuticals
Market Cap: ₹156.7b
An integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally.
APLLTD
₹797.05
7D
-0.07%
1Y
-16.9%
Dr. Reddy's Laboratories
Market Cap: ₹955.9b
Operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally.
500124
₹1,147.60
7D
-0.4%
1Y
-5.9%
Caplin Point Laboratories
Market Cap: ₹191.1b
Engages in the development, production, marketing, and export of generic formulations and branded products in India.
524742
₹2,514.70
7D
2.0%
1Y
26.5%
Pfizer
Market Cap: ₹220.7b
Engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally.
PFIZER
₹4,823.90
7D
4.3%
1Y
-4.6%
Sun Pharmaceutical Industries
Market Cap: ₹4.8t
A generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally.
SUNPHARMA
₹1,990.50
7D
2.5%
1Y
22.1%
Alkem Laboratories
Market Cap: ₹687.7b
A pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally.
ALKEM
₹5,751.50
7D
2.1%
1Y
17.4%
Cipla
Market Cap: ₹1.2t
Manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally.
CIPLA
₹1,473.20
7D
4.4%
1Y
-2.0%
Jubilant Pharmova
Market Cap: ₹148.1b
Operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally.
530019
₹934.80
7D
-2.8%
1Y
-19.5%
Divi's Laboratories
Market Cap: ₹2.1t
Engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally.
DIVISLAB
₹8,056.00
7D
11.1%
1Y
26.6%
Granules India
Market Cap: ₹204.2b
Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), finished dosages (FDs), and peptides CDMO in India and internationally.
532482
₹824.05
7D
-1.2%
1Y
82.4%
J. B. Chemicals & Pharmaceuticals
Market Cap: ₹387.3b
Manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally.
506943
₹2,412.25
7D
0%
1Y
39.0%
Lupin
Market Cap: ₹1.1t
Operates as a pharmaceutical company in India, the United States, and internationally.
500257
₹2,413.95
7D
1.9%
1Y
29.4%
Glenmark Pharmaceuticals
Market Cap: ₹630.4b
Develops, manufactures, and sells generics, specialty medicines, and over the counter (OTC) pharmaceutical products in India, North America, Europe, and internationally.
GLENMARK
₹2,233.90
7D
1.9%
1Y
8.0%
Sanofi Consumer Healthcare India
Market Cap: ₹106.2b
Operates as a fast-moving consumer healthcare company in India.
SANOFICONR
₹4,611.20
7D
-1.4%
1Y
-5.1%
Torrent Pharmaceuticals
Market Cap: ₹1.9t
Engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally.
500420
₹5,102.80
7D
2.9%
1Y
38.9%
Marksans Pharma
Market Cap: ₹117.1b
Engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally.
MARKSANS
₹258.35
7D
4.9%
1Y
14.9%
Syngene International
Market Cap: ₹153.6b
A contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally.
SYNGENE
₹385.90
7D
-5.1%
1Y
-45.1%
NATCO Pharma
Market Cap: ₹164.2b
A pharmaceutical company, engages in the research and development, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally.
NATCOPHARM
₹917.00
7D
-0.5%
1Y
-1.5%
Concord Biotech
Market Cap: ₹148.6b
A biopharma company, engages in the research and development, manufacture, market, and sale of pharmaceutical products in India and internationally.
CONCORDBIO
₹1,420.80
7D
13.8%
1Y
-18.4%
Indegene
Market Cap: ₹124.1b
Operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally.
INDGN
₹515.15
7D
4.6%
1Y
-10.8%
Aurobindo Pharma
Market Cap: ₹909.2b
A biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables.
AUROPHARMA
₹1,580.20
7D
3.1%
1Y
46.3%
Eris Lifesciences
Market Cap: ₹187.7b
Provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally.
ERIS
₹1,354.70
7D
-3.3%
1Y
-25.1%
Ajanta Pharma
Market Cap: ₹432.8b
A pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages.
AJANTPHARM
₹3,465.20
7D
2.8%
1Y
28.6%
Ipca Laboratories
Market Cap: ₹443.4b
An integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India.
IPCALAB
₹1,747.80
7D
-0.8%
1Y
20.5%
Alivus Life Sciences
Market Cap: ₹142.4b
Develops, manufactures, and markets active pharmaceutical ingredients in India, Japan, Europe, North and Latin America, and internationally.
ALIVUS
₹1,160.00
7D
5.3%
1Y
15.9%
Gland Pharma
Market Cap: ₹412.4b
Engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally.
GLAND
₹2,502.90
7D
5.2%
1Y
26.5%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹449.5b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,653.45
7D
5.6%
1Y
-9.6%
CORONA Remedies
Market Cap: ₹128.4b
A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.
CORONA
₹2,098.80
7D
-0.7%
1Y
n/a
AstraZeneca Pharma India
Market Cap: ₹202.6b
A biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally.
506820
₹8,103.65
7D
1.3%
1Y
-8.9%
Blue Jet Healthcare
Market Cap: ₹118.5b
Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.
BLUEJET
₹626.25
7D
10.5%
1Y
-21.4%
Anthem Biosciences
Market Cap: ₹455.7b
Operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally.
ANTHEM
₹809.20
7D
5.1%
1Y
9.6%
Emcure Pharmaceuticals
Market Cap: ₹371.6b
Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.
EMCURE
₹1,960.10
7D
4.2%
1Y
43.7%
Neuland Laboratories
Market Cap: ₹244.6b
Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.
524558
₹19,067.60
7D
2.7%
1Y
46.2%
Laurus Labs
Market Cap: ₹980.5b
Manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.
LAURUSLABS
₹1,816.20
7D
13.4%
1Y
113.8%